Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Redox-dependent Brca1 transcriptional regulation by an NADH-sensor CtBP1.

Deng Y, Liu J, Han G, Lu SL, Wang SY, Malkoski S, Tan AC, Deng C, Wang XJ, Zhang Q.

Oncogene. 2010 Dec 16;29(50):6603-8. doi: 10.1038/onc.2010.406. Epub 2010 Sep 6.

2.

Transcriptional down-regulation of Brca1 and E-cadherin by CtBP1 in breast cancer.

Deng Y, Deng H, Liu J, Han G, Malkoski S, Liu B, Zhao R, Wang XJ, Zhang Q.

Mol Carcinog. 2012 Jun;51(6):500-7. doi: 10.1002/mc.20813. Epub 2011 Jun 16.

3.

CtBP1 is expressed in melanoma and represses the transcription of p16INK4a and Brca1.

Deng H, Liu J, Deng Y, Han G, Shellman YG, Robinson SE, Tentler JJ, Robinson WA, Norris DA, Wang XJ, Zhang Q.

J Invest Dermatol. 2013 May;133(5):1294-301. doi: 10.1038/jid.2012.487. Epub 2013 Jan 10.

4.

Transcriptional regulation of BRCA1 expression by a metabolic switch.

Di LJ, Fernandez AG, De Siervi A, Longo DL, Gardner K.

Nat Struct Mol Biol. 2010 Dec;17(12):1406-13. doi: 10.1038/nsmb.1941. Epub 2010 Nov 21.

5.

Metabolic Reprogramming Regulates the Proliferative and Inflammatory Phenotype of Adventitial Fibroblasts in Pulmonary Hypertension Through the Transcriptional Corepressor C-Terminal Binding Protein-1.

Li M, Riddle S, Zhang H, D'Alessandro A, Flockton A, Serkova NJ, Hansen KC, Moldvan R, McKeon BA, Frid M, Kumar S, Li H, Liu H, Caánovas A, Medrano JF, Thomas MG, Iloska D, Plecitá-Hlavatá L, Ježek P, Pullamsetti S, Fini MA, El Kasmi KC, Zhang Q, Stenmark KR.

Circulation. 2016 Oct 11;134(15):1105-1121. Epub 2016 Aug 25.

PMID:
27562971
6.
7.

Repression of RAD51 gene expression by E2F4/p130 complexes in hypoxia.

Bindra RS, Glazer PM.

Oncogene. 2007 Mar 29;26(14):2048-57. Epub 2006 Sep 25.

PMID:
17001309
8.

MicroRNA-137 targets carboxyl-terminal binding protein 1 in melanoma cell lines.

Deng Y, Deng H, Bi F, Liu J, Bemis LT, Norris D, Wang XJ, Zhang Q.

Int J Biol Sci. 2011 Jan 27;7(1):133-7.

9.

Gain of function mutant p53 proteins cooperate with E2F4 to transcriptionally downregulate RAD17 and BRCA1 gene expression.

Valenti F, Ganci F, Fontemaggi G, Sacconi A, Strano S, Blandino G, Di Agostino S.

Oncotarget. 2015 Mar 20;6(8):5547-66.

10.

Nicotinamide adenine dinucleotide-induced multimerization of the co-repressor CtBP1 relies on a switching tryptophan.

Madison DL, Wirz JA, Siess D, Lundblad JR.

J Biol Chem. 2013 Sep 27;288(39):27836-48. doi: 10.1074/jbc.M113.493569. Epub 2013 Aug 12.

11.

Acetylation-dependent interaction of SATB1 and CtBP1 mediates transcriptional repression by SATB1.

Purbey PK, Singh S, Notani D, Kumar PP, Limaye AS, Galande S.

Mol Cell Biol. 2009 Mar;29(5):1321-37. doi: 10.1128/MCB.00822-08. Epub 2008 Dec 22.

12.

Prostate tumor growth is impaired by CtBP1 depletion in high-fat diet-fed mice.

Moiola CP, De Luca P, Zalazar F, Cotignola J, Rodríguez-Seguí SA, Gardner K, Meiss R, Vallecorsa P, Pignataro O, Mazza O, Vazquez ES, De Siervi A.

Clin Cancer Res. 2014 Aug 1;20(15):4086-95. doi: 10.1158/1078-0432.CCR-14-0322. Epub 2014 May 19.

13.

Epigenetic screen of human DNA repair genes identifies aberrant promoter methylation of NEIL1 in head and neck squamous cell carcinoma.

Chaisaingmongkol J, Popanda O, Warta R, Dyckhoff G, Herpel E, Geiselhart L, Claus R, Lasitschka F, Campos B, Oakes CC, Bermejo JL, Herold-Mende C, Plass C, Schmezer P.

Oncogene. 2012 Dec 6;31(49):5108-16. doi: 10.1038/onc.2011.660. Epub 2012 Jan 30.

PMID:
22286769
14.

BRCA1 expression is epigenetically repressed in sporadic ovarian cancer cells by overexpression of C-terminal binding protein 2.

May T, Yang J, Shoni M, Liu S, He H, Gali R, Ng SK, Crum C, Berkowitz RS, Ng SW.

Neoplasia. 2013 Jun;15(6):600-8.

15.

Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma.

Bennett KL, Hackanson B, Smith LT, Morrison CD, Lang JC, Schuller DE, Weber F, Eng C, Plass C.

Cancer Res. 2007 May 15;67(10):4657-64.

16.

CtBP represses p300-mediated transcriptional activation by direct association with its bromodomain.

Kim JH, Cho EJ, Kim ST, Youn HD.

Nat Struct Mol Biol. 2005 May;12(5):423-8. Epub 2005 Apr 17.

PMID:
15834423
17.

CtBP1 associates metabolic syndrome and breast carcinogenesis targeting multiple miRNAs.

De Luca P, Dalton GN, Scalise GD, Moiola CP, Porretti J, Massillo C, Kordon E, Gardner K, Zalazar F, Flumian C, Todaro L, Vazquez ES, Meiss R, De Siervi A.

Oncotarget. 2016 Apr 5;7(14):18798-811. doi: 10.18632/oncotarget.7711.

18.

E2F-Rb complexes assemble and inhibit cdc25A transcription in cervical carcinoma cells following repression of human papillomavirus oncogene expression.

Wu L, Goodwin EC, Naeger LK, Vigo E, Galaktionov K, Helin K, DiMaio D.

Mol Cell Biol. 2000 Oct;20(19):7059-67.

19.

Phosphorylation of CtBP1 by cAMP-dependent protein kinase modulates induction of CYP17 by stimulating partnering of CtBP1 and 2.

Dammer EB, Sewer MB.

J Biol Chem. 2008 Mar 14;283(11):6925-34. doi: 10.1074/jbc.M708432200. Epub 2008 Jan 9.

20.

Loss of full length CtBP1 expression enhances the invasive potential of human melanoma.

Winklmeier A, Poser I, Hoek KS, Bosserhoff AK.

BMC Cancer. 2009 Feb 12;9:52. doi: 10.1186/1471-2407-9-52.

Supplemental Content

Support Center